| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.8 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | salermide | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |